Oneview Healthcare PLC (ASX: ONE) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Oneview Healthcare PLC Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Oneview Healthcare PLC (ASX: ONE)
Latest News
Share Market News
Here's why the Oneview (ASX:ONE) share price is climbing today
Share Gainers
Up another 6%, Oneview (ASX:ONE) share price hits 10-bagger status today
Healthcare Shares
Why the Oneview (ASX:ONE) share price is climbing today
⏸️ ASX Shares
These 5 ASX shares are delivering the biggest gains in 2021
Healthcare Shares
Oneview (ASX:ONE) share price jumps 15% today. Here's why
Healthcare Shares
Why the Oneview (ASX:ONE) share price is rocketing 29% today
Share Market News
Here's why the Oneview (ASX:ONE) share price is rocketing 14%
Share Market News
Afterpay and Zip were among the most traded ASX shares last week
Share Market News
The Oneview Healthcare (ASX:ONE) share price rockets 650% this year
Share Market News
Here's why the Oneview (ASX:ONE) share price has exploded 106% higher
Share Market News
ASX stock of the day: Why Oneview Healthcare (ASX:ONE) shares are rocketing 140% today
Share Gainers
These small cap ASX shares are on the rise on Friday
ONE ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Oneview Healthcare PLC
Oneview Healthcare PLC provides patient engagement and clinical workflow technology solutions to healthcare facilities. It provides various solutions such as Empower Patients & Families Manage Patient Experience, Deliver Virtual Care, Digital Door Sign, and Digital Whiteboard The company generates its revenue in the form of software usage and content revenue, support income, Hardware, Services income, and license fees. Geographically the company operates in Ireland, the United States, Australia, the Middle East, and Asia. Generating, a majority of its revenue is from the United States. The group has one reportable segment which provides a patient engagement solution for the healthcare sector.
ONE Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
31 Oct 2024 | $0.33 | $0.00 | 0.00% | 36,668 | $0.33 | $0.33 | $0.33 |
30 Oct 2024 | $0.33 | $0.00 | 0.00% | 144,219 | $0.33 | $0.34 | $0.33 |
29 Oct 2024 | $0.33 | $-0.02 | -5.71% | 187,025 | $0.35 | $0.35 | $0.33 |
28 Oct 2024 | $0.35 | $0.02 | 6.06% | 578,282 | $0.34 | $0.36 | $0.34 |
25 Oct 2024 | $0.33 | $0.00 | 0.00% | 26,368 | $0.33 | $0.33 | $0.33 |
24 Oct 2024 | $0.33 | $0.00 | 0.00% | 8,948 | $0.33 | $0.33 | $0.32 |
23 Oct 2024 | $0.33 | $0.01 | 3.08% | 104,285 | $0.33 | $0.33 | $0.33 |
22 Oct 2024 | $0.33 | $0.00 | 0.00% | 116,479 | $0.33 | $0.33 | $0.33 |
21 Oct 2024 | $0.33 | $-0.01 | -3.03% | 122,877 | $0.33 | $0.33 | $0.33 |
18 Oct 2024 | $0.33 | $-0.01 | -2.94% | 98,125 | $0.34 | $0.34 | $0.33 |
17 Oct 2024 | $0.34 | $0.01 | 2.99% | 2,000 | $0.34 | $0.34 | $0.34 |
16 Oct 2024 | $0.34 | $0.00 | 0.00% | 115,328 | $0.34 | $0.34 | $0.34 |
15 Oct 2024 | $0.34 | $0.01 | 3.03% | 33,860 | $0.34 | $0.34 | $0.33 |
14 Oct 2024 | $0.33 | $0.00 | 0.00% | 153,131 | $0.33 | $0.34 | $0.33 |
11 Oct 2024 | $0.33 | $0.01 | 3.08% | 55,128 | $0.33 | $0.33 | $0.33 |
10 Oct 2024 | $0.33 | $-0.01 | -3.03% | 44,800 | $0.33 | $0.33 | $0.33 |
09 Oct 2024 | $0.33 | $0.01 | 3.08% | 22,562 | $0.33 | $0.33 | $0.33 |
08 Oct 2024 | $0.33 | $-0.01 | -2.99% | 149,047 | $0.33 | $0.33 | $0.32 |
07 Oct 2024 | $0.34 | $0.00 | 0.00% | 137,960 | $0.33 | $0.34 | $0.33 |
04 Oct 2024 | $0.34 | $0.01 | 3.03% | 40,228 | $0.33 | $0.34 | $0.33 |
03 Oct 2024 | $0.33 | $0.00 | 0.00% | 90,355 | $0.33 | $0.33 | $0.33 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
15 May 2024 | Nashina Asaria | Exercise | 666,666 | $189,999 |
Conversion of securities. 208,333 Restricted Share Units
|
15 May 2024 | Nashina Asaria | Sell | 337,930 | $101,812 |
As advised by the company. shares to sell mandatory Irish payroll income
taxes on recent vesting of RSUs |
15 May 2024 | Nashina Asaria | Buy | 666,666 | $200,000 |
Conversion of securities.
|
30 Apr 2024 | James Fitter | Expiry | 6,000,000 | $1,770,000 |
As advised by the company. Expiry of Restricted Share Units as vesting
conditions not met |
12 Mar 2024 | Mark Cullen | Sell | 250,000 | $97,500 |
As advised by the company. Sale of shares held buy Trust executed by
Trustee, CDI |
27 Nov 2023 | Joseph Rooney | Sell | 283,928 | $58,346 |
On-market trade. Sale of CDIs over ordinary shares to sell
mandatory Irish payroll income taxes on recent vesting of RSUs |
27 Nov 2023 | Nashina Asaria | Sell | 175,000 | $36,320 |
As advised by the company. Sale of CDIs over ordinary shares to sell
mandatory Irish payroll income taxes on recent vesting of RSUs |
20 Nov 2023 | Nashina Asaria | Exercise | 357,143 | $71,429 |
Conversion of securities. 874,999 Restricted Share Units,Value
|
20 Nov 2023 | Nashina Asaria | Issued | 357,143 | $71,429 |
Conversion of securities. Value, cdi
|
20 Nov 2023 | Joseph Rooney | Exercise | 535,714 | $107,142 |
Conversion of securities. 470,833 Restricted Share Units , value
|
20 Nov 2023 | Joseph Rooney | Issued | 535,714 | $107,143 |
Conversion of securities. Value, CDIS
|
20 Nov 2023 | James Fitter | Exercise | 664,286 | $132,857 |
Conversion of securities. Value, 18,000,000 Restricted Share Units
|
20 Nov 2023 | James Fitter | Issued | 664,286 | $132,857 |
Conversion of securities. Value
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr James Fitter | Chief Executive OfficerExecutive Director | Jan 2013 |
Mr Fitter has helping transition what was then a 10 person start up into a publicly traded Company in just over three years. He has over 25 years' experience in the global financial markets during which time he has lived and worked on four continents. James founded and managed an independent asset management company and spent over ten years as a professional investor and an independent advisor prior to joining Oneview.
|
Mr Joseph Rooney | Non-Executive Director | Feb 2016 |
Mr Rooney assumed the role of Interim Chairman in July 2023, subsequent to the retirement of Michael Kaminski. Joseph had taken on this role before, upon the death of our first Chairman, James Osborne. Joseph is also Chair of Fundraising for the Clongowes Wood College Foundation. Until the end of 2012, Joseph was a partner and global strategist at Autonomy Capital Research LLP, a global macro hedge fund. Prior to this, he held a number of senior positions at Lehman Brothers Inc, including Managing Director, Head of Global Strategy and trustee of their UK pension fund.
|
Mr Mark Cullen | Non-Executive Director | Dec 2015 |
Mr Cullen is rejoining the Board after recently retiring from a distinguished 30 year career with Deutsche Bank and DWS Asset Management, most recently as CEO of DWS Americas & COO of DWS Group GmbH & Co. Mark was previously the Global Head of Audit for Deutsche Bank from March 2015 to December 2018. Mark was appointed to the Board in October 2023.
|
Ms Nashina Asaria | Non-Executive Director | May 2021 |
Ms Asaria is a corporate board member, advisor and C level global executive with a track record of driving high growth in private and public companies across the health, fintech and mobile industries. She is an advisor to SimBioSys (a spacial biophysics company using AI and data science to drive precision medicine and better outcomes for breast cancer patients), Cylerity (using AI to provide cash advance and revenue recovery to the healthcare industry), InTech Energy (software and hardware solution for air purification and quality and energy expense management) and ExtoLabs (applying blockchain and AI into combined hardware and software platform for financial and healthcare inclusion). Nashina was Chief Product & Marketing Officer (CPMO) for Nanthealth. Prior to Nanthealth, she was CPMO of UpHealth Inc. Nashina was Chief Product Officer at Cloudbreak Health LLC, a US telehealth company that was merged into UpHealth Inc. in June 2021. She has held leadership roles with LifeQ, Nantworks, Verifone and Qualcomm. Nashina was appointed to the Board in 2021.
|
Ms Barbara Nelson | Non-Executive Director | Oct 2023 |
Ms Nelson is a public board director and C level technology leader, who currently serves on four corporate boards. She has been CEO twice and led global P&Ls as large as US$4 billion in companies ranging from Fortune 500 leaders to VC-funded companies. Barbara has scaled from concept to over US$100 million -US$200 million, four times in three companies, delivering profitability each time. She brings over 15 years of Board, P&L and general management experience in AI, SaaS/cloud services, IaaS, cybersecurity, board, software, mobile, video, data management, storage, IT infrastructure, and semiconductors.
|
Mr Darragh Lyons | Chief Financial OfficerNon-executive director | Sep 2024 |
Mr Lyons brings over 20 years of experience in finance, accounting, and business leadership to Oneview. He previously served as both the CEO and CFO of Malin Corporation plc, a publicly traded investment company that invests in and supports highly innovative life sciences companies developing exceptional science and technology. Darragh Lyons joined Malin as chief financial officer in March 2015 and was appointed chief business and financial officer in November 2018. Darragh was appointed chief executive officer in September 2019. Prior to joining Malin, Darragh held several senior finance positions in the pharmaceutical group Elan Corporation plc and worked with PwC in Dublin, the United States, and Canada.
|
Ms Toni Pettit | Company Secretary | Sep 2024 |
-
|
Toni Pettit | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Hsbc Custody Nominees (Australia) Limited | 199,835,075 | 29.60% |
Bell Potter Nominees Ltd <Bb Nominees A/C> | 69,301,674 | 10.30% |
Citicorp Nominees Pty Limited | 61,689,941 | 9.10% |
Ubs Nominees Pty Ltd | 30,547,204 | 4.50% |
HSBC Custody Nominees (Australia) Limited GSI EDA | 27,189,768 | 4.00% |
Hsbc Custody Nominees (Australia) Limited A/C 2 | 16,824,365 | 2.50% |
James Fitter | 14,933,090 | 2.20% |
Bnp Paribas Noms Pty Ltd | 14,856,524 | 2.20% |
Manderrah Pty Limited | 12,083,333 | 1.80% |
Longbridge Nominees Pty Limited <Longbridge A/C> | 11,111,111 | 1.60% |
HSBC Custody Nominees (Australia) Limited III | 9,106,033 | 1.40% |
Bnp Paribas Noms Pty Ltd <Global Markets> | 7,498,502 | 1.10% |
S3 Consortium Holdings Pty Ltd <Nextinvestors Dot Com A/C> | 6,748,333 | 1.00% |
Barana Capital Pty Limited <Shand Family A/C> | 6,198,371 | 0.90% |
AJA Investments Pty Ltd <The Oliver Amelia Prop A/C> | 5,555,556 | 0.80% |
Mark McCloskey | 5,479,868 | 0.80% |
Berne No 132 Nominiees Pty Ltd <W 1253672 A/C> | 5,161,111 | 0.80% |
Top 4 Pty Ltd <The Foundation Inv S/F A/C> | 4,800,000 | 0.70% |
J P Morgan Nominees Australia Pty Limited | 4,681,543 | 0.70% |
Walling Pty Ltd <CJ Howard Super Fund A/C> | 4,239,298 | 0.60% |